Add Yahoo as a preferred source to see more of our stories on Google. Compounded GLP-1 drugs aren't FDA-approved and may carry unknown safety risks. Experts warn of inconsistent quality, dosing and ...

The FDA is taking no prisoners as it continues its efforts to combat widespread GLP-1 drug compounding. | In the letters sent ...

Pharmacy compounding is one of the topics in the EU Pharma Law Package that has perhaps received less attention compared to topics such as regulatory exclusivity rights, shortages, and sustainability.

Over the past few weeks, the FDA has devoted lots of attention to compounding pharmacies, issuing two new guidance documents pertaining to their fundamental scope, a guidance document regarding ...

WEST LAFAYETTE, Ind., and INDIANAPOLIS – A Purdue-related startup is developing the first USP 797 certified, virtual pharmacy cleanroom laboratory for students and other industry professionals to gain ...

When you have to go on a medication, your doctor will probably prescribe a premade one that's FDA-approved. But sometimes, they may want you to go on a compounded medicine that's specifically made for ...

In 2017, the FDA approved semaglutide, an injectable GLP-1 agonist medication sold under the name Ozempic, for the management of type 2 diabetes. Later, the pharmaceutical company that makes Ozempic ...

Before you fill that prescription. Reviewed by Dietitian Maria Laura Haddad-Garcia Compounded GLP-1 drugs aren't FDA-approved and may carry unknown safety risks. Experts warn of inconsistent quality, ...

Compounded GLP-1 drugs aren't FDA-approved and may carry unknown safety risks. Experts warn of inconsistent quality, dosing and possible side effects in compounded meds. Lifestyle habits—like diet, ...